Tag: pharmaceutical competition

Antitrust Issues in Generic Substitution: How Pharma Tactics Block Cheaper Drugs

Barbara Lalicki January 29, 2026 Pharmacy 5 Comments

Pharmaceutical companies are using legal loopholes to block generic drugs from replacing brand-name medications, costing patients and taxpayers billions. Learn how product hopping and REMS abuse undermine competition - and what’s being done to stop it.

First Generic vs Authorized Generic: How Timing of Market Entry Changes Everything

Barbara Lalicki December 12, 2025 Pharmacy 8 Comments

First generics get 180 days of exclusivity, but brand companies can launch their own authorized generics on day one - splitting the market and keeping prices higher. Here’s how timing changes everything.